Nu-Med Plus (NUMD) Change in Account Payables (2012 - 2025)
Nu-Med Plus (NUMD) posted Change in Account Payables of $356.0 for Q4 2025, up 104.84% sequentially from -$7357.0 in Q3 2025, and down 98.46% YoY from $23190.0 in Q4 2024.
Nu-Med Plus (NUMD) Change in Account Payables (2012 - 2025) Analysis & Trends
Nu-Med Plus has reported Change in Account Payables for 14 years, with the latest figure at $356.0 in Q4 2025.
- Quarterly Change in Account Payables fell 98.46% year-over-year to $356.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5163.0 (down 85.23% YoY) and the FY2025 annual result came in at $5163.0, down 85.23% from the prior year.
- Change in Account Payables climbed to $356.0 in Q4 2025 per NUMD's latest filing, from -$7357.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $35200.0 in Q4 2021 and troughed at -$44175.0 in Q4 2022.
- A 5-year average of $2807.7 and a median of $1028.0 in 2023 frame the typical range for Change in Account Payables.
- The sharpest annual moves came in 2023 and 2024: Change in Account Payables plunged 4082.51% in 2023, then surged 1441.89% in 2024.
- Over 5 years, Change in Account Payables stood at $35200.0 in 2021, then slumped by 225.5% to -$44175.0 in 2022, then surged by 103.4% to $1504.0 in 2023, then soared by 1441.89% to $23190.0 in 2024, then sank by 98.46% to $356.0 in 2025.
- According to Business Quant data, Change in Account Payables over the past three periods registered $356.0, -$7357.0, and $12209.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.28 Bn | 193.68 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.49 Bn | 126.02 Bn | 4.50 Bn | 71.00 Mn |
| 3 | Medtronic | 119.55 Bn | 110.33 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.67 Bn | 73.13 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.28 Bn | 48.03 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | -200.00 Mn |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | - |
| 9 | Steris | 23.17 Bn | 22.69 Bn | 684.20 Mn | 4.30 Mn |
| 10 | Nu-Med Plus | 2.03 Mn | 2.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 356.00 |
| Dec 31, 2025 | 356.00 |
| Sep 30, 2025 | -7,357.00 |
| Sep 30, 2025 | -7,357.00 |
| Jun 30, 2025 | 12,209.00 |
| Jun 30, 2025 | 12,209.00 |
| Mar 31, 2025 | -45.00 |
| Mar 31, 2025 | -45.00 |
| Dec 31, 2024 | 23,190.00 |
| Dec 31, 2024 | 23,190.00 |
| Sep 30, 2024 | 9,583.00 |
| Sep 30, 2024 | 9,583.00 |
| Jun 30, 2024 | -6,190.00 |
| Jun 30, 2024 | -6,190.00 |
| Mar 31, 2024 | 8,368.00 |
| Mar 31, 2024 | 8,368.00 |
| Dec 31, 2023 | 1,504.00 |
| Dec 31, 2023 | 1,504.00 |
| Sep 30, 2023 | -7,654.00 |
| Sep 30, 2023 | -7,654.00 |